BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15143469)

  • 1. Familial clustering of classic Kaposi sarcoma.
    Guttman-Yassky E; Cohen A; Kra-Oz Z; Friedman-Birnbaum R; Sprecher E; Zaltzman N; Friedman E; Silbermann M; Rubin D; Linn S; Whitby D; Gideoni O; Pollack S; Bergman R; Sarid R
    J Infect Dis; 2004 Jun; 189(11):2023-6. PubMed ID: 15143469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma.
    Kimball LE; Casper C; Koelle DM; Morrow R; Corey L; Vieira J
    J Infect Dis; 2004 Jun; 189(11):2016-22. PubMed ID: 15143468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A common genetic variant in FCGR3A-V158F and risk of Kaposi sarcoma herpesvirus infection and classic Kaposi sarcoma.
    Brown EE; Fallin MD; Goedert JJ; Chen R; Whitby D; Foster CB; Lauria C; Alberg AJ; Messina A; Montella M; Rezza G; Vitale F; Chanock SJ;
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):633-7. PubMed ID: 15767342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classic Kaposi sarcoma. Which KSHV-seropositive individuals are at risk?
    Guttman-Yassky E; Dubnov J; Kra-Oz Z; Friedman-Birnbaum R; Silbermann M; Barchana M; Bergman R; Sarid R
    Cancer; 2006 Jan; 106(2):413-9. PubMed ID: 16353205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interleukin-6-174 promoter polymorphism is associated with a risk of development of Kaposi's sarcoma in renal transplant recipients.
    Gazouli M; Zavos G; Papaconstantinou I; Lukas JC; Zografidis A; Boletis J; Kostakis A
    Anticancer Res; 2004; 24(2C):1311-4. PubMed ID: 15154666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of classic Kaposi sarcoma with common variants in genes that modulate host immunity.
    Brown EE; Fallin D; Ruczinski I; Hutchinson A; Staats B; Vitale F; Lauria C; Serraino D; Rezza G; Mbisa G; Whitby D; Messina A; Goedert JJ; Chanock SJ
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):926-34. PubMed ID: 16702372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classic kaposi sarcoma: epidemiology and risk factors.
    Iscovich J; Boffetta P; Franceschi S; Azizi E; Sarid R
    Cancer; 2000 Feb; 88(3):500-17. PubMed ID: 10649240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between the quantity of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated disease.
    Marcelin AG; Motol J; Guihot A; Caumes E; Viard JP; Dussaix E; Cadranel J; Frances C; Carcelain G; Calvez V; Dupin N
    J Infect Dis; 2007 Oct; 196(8):1163-6. PubMed ID: 17955434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.
    Abe Y; Matsubara D; Gatanaga H; Oka S; Kimura S; Sasao Y; Saitoh K; Fujii T; Sato Y; Sata T; Katano H
    Pathol Int; 2006 Oct; 56(10):617-24. PubMed ID: 16984619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of Kaposi sarcoma (KS)-associated herpesvirus viremia and KS disease in Zimbabwe.
    Campbell TB; Borok M; White IE; Gudza I; Ndemera B; Taziwa A; Weinberg A; Gwanzura L
    Clin Infect Dis; 2003 May; 36(9):1144-51. PubMed ID: 12715309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas?
    Lazzi S; Bellan C; Amato T; Palummo N; Cardone C; D'Amuri A; De Luca F; Beyanga M; Facchetti F; Tosi P; Leoncini L
    Hum Pathol; 2006 Jan; 37(1):23-31. PubMed ID: 16360412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial Kaposi's Sarcoma in HHV8 infected subjects presenting the G-174C allele of the IL-6 promoter: a possible role for EBV?
    Cordiali-Fei P; Latini A; Trento E; Zampatti S; Ferraresi V; Cota C; Volpi S; D'agosto G; Bordignon V; Giardina E; Di Carlo A; Cristaudo A; Ensoli F
    Eur J Dermatol; 2014; 24(4):503-4. PubMed ID: 24898204
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibodies against Kaposi sarcoma-associated herpes virus (KSHV) complement control protein (KCP) in infected individuals.
    Okroj M; Spiller OB; Korodi Z; Tedeschi R; Dillner J; Blom AM
    Vaccine; 2007 Nov; 25(48):8102-9. PubMed ID: 17964697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human bcl-2 expression, cleaved caspase-3, and KSHV LANA-1 in Kaposi sarcoma lesions.
    Ramos da Silva S; Bacchi MM; Bacchi CE; Elgui de Oliveira D
    Am J Clin Pathol; 2007 Nov; 128(5):794-802. PubMed ID: 17951202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of quantitative Kaposi sarcoma--associated herpesvirus load in posttransplantation Kaposi sarcoma.
    Pellet C; Chevret S; Francès C; Euvrard S; Hurault M; Legendre C; Dalac S; Farge D; Antoine C; Hiesse C; Peraldi MN; Lang P; Samuel D; Calmus Y; Agbalika F; Morel P; Calvo F; Lebbé C
    J Infect Dis; 2002 Jul; 186(1):110-3. PubMed ID: 12089670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma.
    Guihot A; Dupin N; Marcelin AG; Gorin I; Bedin AS; Bossi P; Galicier L; Oksenhendler E; Autran B; Carcelain G
    J Infect Dis; 2006 Oct; 194(8):1078-88. PubMed ID: 16991082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
    de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
    J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
    Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
    Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pleiotropic effects of Kaposi's sarcoma herpesvirus.
    Schulz TF
    J Pathol; 2006 Jan; 208(2):187-98. PubMed ID: 16362980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.